drugset / Trial / NCT06715826
Target-specific immunoPET Imaging of Breast Cancer
NaSingle-groupOpen-labelDiagnostic
Summary
The aim of this study is to establish and optimize the Trop2/HER2-targeted PET/CT imaging method, and its physiological and pathological distribution characteristics, on the basis of which the diagnostic efficacy of the above imaging agents in breast cancer will be evaluated.
Timeline
- Start
- 2024-09-21
- Primary completion
- 2026-11
- Completion
- 2026-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [18F]F-RESCA-RB14 | Unknown | 1.85 mbq/kg | — |
| Subject | [18F]F-RESCA-RB14 | Unknown | 3.7 mbq/kg | — |
| Subject | [18F]F-RESCA-RT4 | Unknown | 1.85 mbq/kg | — |
| Subject | [18F]F-RESCA-RT4 | Unknown | 3.7 mbq/kg | — |